1. All Products
  2. D - Drugs
  3. MONTELUKAST, 5mg, chewable tab.
Public Pricelist

MONTELUKAST, 5mg, chewable tab.

https://unicat.msf.org/cat/product/66321
STD DORAMONT5TC

Valid Article

Former Code(s): DORAOCBZLB0014 DORAZNL0337
Article is intended to be used with children (<12 years) ONLY.
25.1 - Antiasthmatic medicines and medicines for chronic obstructive pulmonary disease
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
R03DC03
Anatomical Therapeutic Chemical Classification according to WHOCC
P
The order of this product needs to be justified and is only acceptable under certain conditions.
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)
https://www.unicat.msf.org/web/image/product.template/587624/image_1920?unique=cdf3b6c

This combination does not exist.

See Related

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

MONTELUKAST

Therapeutic Action

Leukotriene receptor antagonist (LTRA)

Indications

Add-on maintenance therapy for chronic asthma in children aged 5 to 12 years who do not respond to inhaled corticosteroids (ICS, e.g. inhaled beclometasone) and Long-Acting Beta2 Agonist (LABA, e.g. inhaled salmeterol). In that case, montelukast will be added to the ICS + LABA regimen.

Some restricted information has been hidden. Sign in to see this information

Instructions for use

The tablets must be chewed before swallowing.

Precautions for Use

Never administer alone. Use in combination with an inhaled corticosteroid (ICS) and/or Long-Acting Beta2 Agonist (LABA).

Do not use for the treatment of an acute asthma attack.

Avoid during pregnancy and breastfeeding, if possible due to limited data.

Adverse effects: headache, gastrointestinal disturbances, skin reactions, increased risk of upper respiratory tract infections.

Storage

Below 25ºC Protect from sunlight - Protect from humidity